Protagenic Therapeutics Announces Third Quarter 2021 Results and Business Update

Provided By Globe Newswire

Last update: Nov 16, 2021

NEW YORK, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a biopharmaceutical company focused on developing therapies to treat stress-related neurologic disorders, today announced results for the third quarter ended September 30, 2021.